Acupuncture in Neonatal Abstinence Syndrome (NAS) Babies
AA NAS
Acupuncture Use in Infants Treated for Neonatal Abstinence Syndrome: a Pilot Study
1 other identifier
interventional
21
1 country
1
Brief Summary
This pilot study is intended to assess feasibility of auricular acupuncture in NAS infants who require pharmacologic therapy. We intend to evaluate acceptability of auricular acupuncture, infant tolerance, recruitment strategies, and methodological issues. We plan to also test and generate hypotheses in preparation to apply for funding a larger randomized controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2014
CompletedFirst Submitted
Initial submission to the registry
February 5, 2014
CompletedFirst Posted
Study publicly available on registry
February 13, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedResults Posted
Study results publicly available
January 16, 2019
CompletedJuly 17, 2019
July 1, 2019
1.2 years
February 5, 2014
August 11, 2016
July 15, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Number of Participants With Skin Breakdown and / or Cellulitis
up to 57 days
Percentage of Dislodged Needles
Within three days of placement
Study Arms (1)
NAS babies
EXPERIMENTALAcupuncture for NAS
Interventions
Eligibility Criteria
You may qualify if:
- Gestational age ≥37.0 wks assessed by the obstetrical team from dating of last menstrual period, ultrasound, or best obstetric estimate
- Admitted to NICU with diagnosis of NAS requiring pharmacologic therapy
- Parents give written consent within 72 hours of infant receiving first dose of methadone
You may not qualify if:
- Helix or antihelix of ear is deformed and needle is unable to be placed
- A suspected or confirmed genetic or metabolic syndrome
- Custody retained by the Department of Children and Families
- Any skin condition involving the ear(s)
- Suspected or documented infection at the time of enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tampa General Hospital
Tampa, Florida, 33606, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Laura Weathers
- Organization
- USF Pediatrics
Study Officials
- PRINCIPAL INVESTIGATOR
Laura Weathers, MD
University of South Florida
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 5, 2014
First Posted
February 13, 2014
Study Start
February 1, 2014
Primary Completion
May 1, 2015
Study Completion
October 1, 2015
Last Updated
July 17, 2019
Results First Posted
January 16, 2019
Record last verified: 2019-07